Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02787668 · ClinicalTrials.gov registry record · NA

A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
27
Enrollment target

NCT02787668: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT02787668 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02787668, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effects of a low carbohydrate diet vs a low fat diet on improvement in aminotransferases, hepatic fat infiltration, markers of inflammation, insulin resistance, and body composition in obese adolescents with non-alcoholic fatty liver disease (NAFLD).

Interventions

  • OTHER Carbohydrate-restricted diet
  • OTHER Control, low-fat diet

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2016-05
Est. Completion 2018-04
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT02787668 record still lists

NCT02787668 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Carbohydrate-restricted diet is the first listed.

NCT02787668 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02787668 about?

NCT02787668 is a clinical study titled "A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity". The purpose of this study is to determine the effects of a low carbohydrate diet vs a low fat diet on improvement in aminotransferases, hepatic fat infiltration, markers of inflammation, insulin resistance, and body composition in obese adolescents with non-alcoholic fatty liver disease (NAFLD).

What is the current status of trial NCT02787668?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2016-05. Estimated completion is 2018-04.

What interventions are being tested in trial NCT02787668?

The interventions under investigation include: Carbohydrate-restricted diet (OTHER), Control, low-fat diet (OTHER).

Who is sponsoring clinical trial NCT02787668?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02787668's enrollment target sits among peer trials

27 1708th of 2000 higher than 291 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02787668, the US trial registry maintained by the National Library of Medicine. NCT02787668 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.